July 30, 2015By Mark Terry, BioSpace.com Breaking News Staff Reportedly, almost 200 former GlaxoSmithKline (GSK) employees who were transferred earlier this year to Parexel (PRXL) are being laid off today. The company has declined to comment directly on the matter. In December 2014, Boston, Mass.-based Parexel (PRXL) announced it was hiring 450 former GSK employees. […]

July 29, 2015By Alex Keown, BioSpace.com Breaking News Staff BOSTON – It’s been the year of deal making with more than $220 billion spent on mergers and acquisitions in the biotech industry, and it’s not over yet. Although no M&A activity has been announced, at least as of this writing, but given the atmosphere that […]

By Tess Stynes The Wall Street Journal Biography @TessStynes [email protected] July 29, 2015 4:42 p.m. ET   Vertex Pharmaceuticals Inc. said its second-quarter revenue rose 20% on strong sales of Kalydeco that led the biotechnology company to raise its 2015 sales guidance for the cystic-fibrosis drug. Shares rose 1.5% to $127.50 in recent after-hours trading […]

Teva Pharmaceutical Industries may have found the deal it wanted in purchasing Allergan’s generics business for $40.5 billion in cash and stock, but the Israeli pharmaceutical company stands to lose around $300 million from its tactics in a now withdrawn unsolicited bid for competitor Mylan. Such are the costs of dealmaking in the red hot pharmaceutical and […]